News Category Global Banking & Finance Reviews
Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer
Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for
Early Detection of Lung Cancer
Research Collaboration to be led by the University of Southampton and
along with several major diagnostics and informatics companies will test the best way of detecting cancers at a stage when they can still be cured
Inivata’s InVision
Liquid Biopsy platform will be used to detect mutations in ctDNA in study participants
Research Triangle Park, NC, USA and Cambridge, UK, 18 December 2020 – Inivata, a leader in liquid biopsy, today announces its participation in a major research collaboration to investigate integrated diagnostics for the early detection of lung cancer with the aim of increasing survival rates, alongside improving the efficiency of testing in people at high risk of cancer in the NHS. The program’s goal is to streamline the process of detecting cancers and reduce the NHS resources that are needed in order to find each new case.